Literature DB >> 27541064

Pancreatic cancer tissue banks: where are we heading?

Vickna Balarajah1,2, Archana Ambily1, Abu Z Dayem Ullah1, Ahmet Imrali1, Thomas Dowe1, Bilal Al-Sarireh3, Mohammed Abu Hilal4, Brian R Davidson5, Zahir Soonawalla6, Matthew Metcalfe7, Jo-Anne Chin Aleong2, Claude Chelala1, Hemant M Kocher1,2.   

Abstract

Entities:  

Keywords:  biomarker; biorepository; database; genomics; treatment

Mesh：

Year:  2016        PMID： 27541064     DOI： 10.2217/fon-2016-0243

Source DB:  PubMed          Journal:  Future Oncol        ISSN： 1479-6694            Impact factor:   3.404


× No keyword cloud information.
  3 in total

1.  Pentraxin 3 is a stromally-derived biomarker for detection of pancreatic ductal adenocarcinoma.

Authors:  Michelle R Goulart; Jennifer Watt; Imran Siddiqui; Rita T Lawlor; Ahmet Imrali; Christine Hughes; Amina Saad; Joanne ChinAleong; Chris Hurt; Catrin Cox; Roberto Salvia; Alberto Mantovani; Tatjana Crnogorac-Jurcevic; Somnath Mukherjee; Aldo Scarpa; Paola Allavena; Hemant M Kocher
Journal:  NPJ Precis Oncol       Date:  2021-06-29

2.  The Pancreatic Expression Database: 2018 update.

Authors:  Jacek Marzec; Abu Z Dayem Ullah; Stefano Pirrò; Emanuela Gadaleta; Tatjana Crnogorac-Jurcevic; Nicholas R Lemoine; Hemant M Kocher; Claude Chelala
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

Review 3.  Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee.

Authors:  Brian Gastman; Piyush K Agarwal; Adam Berger; Genevieve Boland; Stephen Broderick; Lisa H Butterfield; David Byrd; Peter E Fecci; Robert L Ferris; Yuman Fong; Stephanie L Goff; Matthew M Grabowski; Fumito Ito; Michael Lim; Michael T Lotze; Haider Mahdi; Mokenge Malafa; Carol D Morris; Pranav Murthy; Rogerio I Neves; Adekunle Odunsi; Sara I Pai; Sangeetha Prabhakaran; Steven A Rosenberg; Ragheed Saoud; Jyothi Sethuraman; Joseph Skitzki; Craig L Slingluff; Vernon K Sondak; John B Sunwoo; Simon Turcotte; Cecilia Cs Yeung; Howard L Kaufman
Journal:  J Immunother Cancer       Date:  2020-11       Impact factor: 12.469
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.